Drug Use Can Trigger Psychosis and Raise Schizophrenia Risk

Substances like cannabis, stimulants, and hallucinogens can sometimes do more than cause a temporary high. In some people, they can trigger substance-induced psychosis, a serious break from reality that may look and feel very similar to schizophrenia. In a significant number of cases, that initial episode becomes the starting point of a long-term psychiatric illness.

Understanding the warning signs, risk factors, and treatment options is critical for early intervention and better outcomes.

Drug-Induced Psychosis vs. Schizophrenia

Drug-induced psychosis occurs when hallucinations, delusions, or disorganized thinking develop during or shortly after using or withdrawing from a substance. For many people, these symptoms fade once the substance leaves the body and the brain stabilizes.

However, research shows that more than one in four people who experience substance-induced psychosis will later receive a diagnosis of schizophrenia. While the two conditions share symptoms, schizophrenia is a chronic, ongoing disorder that persists well beyond substance use.

Schizophrenia itself affects an estimated 0.3% to 0.7% of people worldwide, typically beginning in late adolescence or early adulthood.

Substances Most Commonly Linked to Schizophrenia Risk

Not all substances carry the same risk. Studies suggest the highest likelihood of transitioning from substance-induced psychosis to schizophrenia is associated with:

• Cannabis, including smoking, edibles, teas, and some concentrates

• Hallucinogens, such as LSD and PCP

• Stimulants, including methamphetamine and prescription amphetamines

Alcohol, opioids, and sedatives are also associated with psychosis, though the transition rate to schizophrenia appears somewhat lower.

Why Cannabis Gets Special Attention

The relationship between cannabis and schizophrenia is complex. Some research suggests cannabis use may slightly increase the risk of developing schizophrenia, particularly in people who start young or use high-potency products. Cannabis can also worsen symptoms in people who already have schizophrenia.

At the same time, certain components of cannabis most notably cannabidiol (CBD) are being studied for possible therapeutic effects in established schizophrenia. As legalization expands, researchers continue to examine both risks and potential benefits.

Who Is at Higher Risk?

Substance-induced psychosis alone is a major risk factor, but other characteristics increase the likelihood of developing schizophrenia later, including:

• Being male

• Experiencing psychosis at a younger age

• Having a longer initial hospital stay

• A family history of schizophrenia or related psychiatric conditions

Genetics plays a strong role. Some studies suggest overlapping genetic factors may influence both vulnerability to schizophrenia and sensitivity to drug-induced psychosis.

Key Symptoms to Watch For

Symptoms of schizophrenia and drug-induced psychosis fall into several main categories:

• Hallucinations: Hearing voices or seeing things that aren’t there

• Delusions: Fixed false beliefs, such as being watched, controlled, or having special powers

• Disorganized speech or behavior: Jumping between topics, incoherent language, or unusual actions

Other features may include flat emotional expression, social withdrawal, or catatonic behavior. Many people have little insight into their symptoms and genuinely believe their experiences are real.

Acute psychotic episodes can last days to months and may require hospitalization for safety and stabilization.

How the Condition Is Diagnosed

Mental health professionals diagnose schizophrenia using criteria from the DSM-5. A diagnosis requires at least one core symptom hallucinations, delusions, or disorganized speech plus additional symptoms that significantly interfere with daily life for at least one month.

Imaging studies like MRI or CT scans and blood or urine tests are not diagnostic on their own, but they help rule out medical causes and confirm recent substance exposure. Distinguishing schizophrenia from substance-induced psychotic disorder is essential, since only a subset of people progress to a chronic illness.

Treatment Options That Can Help

Treatment focuses on reducing symptoms, preventing relapse, and supporting daily functioning.

Hospitalization

Hospital care is often necessary during acute psychosis, particularly if there is risk of self-harm, overdose, or inability to care for basic needs. Research suggests up to 25% of first-time psychosis hospitalizations involve substance-induced symptoms.

Medication

Antipsychotic medications are the cornerstone of schizophrenia treatment. Both older and newer antipsychotics are used, and studies show they can reduce relapse rates by around 60% when taken consistently. Additional medications may help manage substance withdrawal.

Psychotherapy and Ongoing Support

Talk therapy, substance-use treatment, and community support services are critical for long-term stability. Addressing ongoing drug or alcohol use is especially important, as substances can trigger future psychotic episodes.

Long-Term Outlook

Schizophrenia is a lifelong condition, but many people experience periods of stability with appropriate treatment. Early diagnosis, consistent care, and avoiding substance use can significantly improve quality of life and reduce the frequency of severe episodes.

If this article was helpful, consider sharing it or subscribing to our newsletter.